González Marco I, Susarla Bala T S, Fournier Keith M, Sheldon Amanda L, Robinson Michael B
Departments of Pediatrics and Pharmacology, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
J Neurochem. 2007 Dec;103(5):1917-31. doi: 10.1111/j.1471-4159.2007.04881.x. Epub 2007 Sep 14.
The neuronal glutamate transporter, excitatory amino acid carrier 1 (EAAC1), has a diverse array of physiologic and metabolic functions. There is evidence that there is a relatively large intracellular pool of EAAC1 both in vivo and in vitro, that EAAC1 cycles on and off the plasma membrane, and that EAAC1 cell surface expression can be rapidly regulated by intracellular signals. Despite the possible relevance of EAAC1 trafficking to both physiologic and pathologic processes, the cellular machinery involved has not been defined. In the present study, we found that agents that disrupt clathrin-dependent endocytosis or plasma membrane cholesterol increased steady-state levels of biotinylated EAAC1 in C6 glioma cells and primary neuronal cultures. Acute depletion of cholesterol increased the V(max) for EAAC1-mediated activity and had no effect on Na(+)-dependent glycine transport in the same system. These agents also impaired endocytosis as measured using a reversible biotinylating reagent. Co-expression with dominant-negative variants of dynamin or the clathrin adaptor, epidermal growth factor receptor pathway substrate clone 15, increased the steady-state levels of biotinylated myc-EAAC1. EAAC1 immunoreactivity was found in a subcellular fraction enriched in early endosome antigen 1 (EEA1) isolated by differential centrifugation and partially co-localized with EEA1. Co-expression of a dominant-negative variant of Rab11 (Rab11 S25N) reduced steady-state levels of biotinylated myc-EAAC1 and slowed constitutive delivery of myc-EAAC1 to the plasma membrane. Together, these observations suggest that EAAC1 is constitutively internalized via a clathrin- and dynamin-dependent pathway into early endosomes and that EAAC1 is trafficked back to the cell surface via the endocytic recycling compartment in a Rab11-dependent mechanism. As one defines the machinery required for constitutive trafficking of EAAC1, it may be possible to determine how intracellular signals regulate EAAC1 cell surface expression.
神经元谷氨酸转运体,即兴奋性氨基酸载体1(EAAC1),具有多种生理和代谢功能。有证据表明,在体内和体外,EAAC1在细胞内都有相对较大的储备池,EAAC1在质膜上循环进出,并且EAAC1的细胞表面表达可被细胞内信号快速调节。尽管EAAC1的转运可能与生理和病理过程都相关,但其中涉及的细胞机制尚未明确。在本研究中,我们发现破坏网格蛋白依赖性内吞作用或质膜胆固醇的试剂会增加C6胶质瘤细胞和原代神经元培养物中生物素化EAAC1的稳态水平。急性去除胆固醇会增加EAAC1介导活性的最大反应速度(Vmax),并且对同一系统中钠依赖性甘氨酸转运没有影响。这些试剂还会损害使用可逆生物素化试剂所检测到的内吞作用。与发动蛋白或网格蛋白衔接蛋白(表皮生长因子受体途径底物克隆15)的显性负变体共表达,会增加生物素化的myc-EAAC1的稳态水平。在通过差速离心分离的富含早期内体抗原1(EEA1)的亚细胞组分中发现了EAAC1免疫反应性,并且与EEA1部分共定位。Rab11(Rab11 S25N)的显性负变体的共表达降低了生物素化的myc-EAAC1的稳态水平,并减缓了myc-EAAC1向质膜的组成型转运。总之,这些观察结果表明,EAAC1通过网格蛋白和发动蛋白依赖性途径组成型内化到早期内体中,并且EAAC1通过Rab11依赖性机制通过内吞循环区室再循环回到细胞表面。随着人们确定EAAC1组成型转运所需的机制,也许有可能确定细胞内信号如何调节EAAC1的细胞表面表达。